CANDIDATE: Heidi M Crane, MD, MPH is currently completing an Infectious Disease Fellowship at the University of Washington. Her long-term interest in complications of HIV disease has developed into a specific interest in the epidemiology of metabolic complications among HIV-infected patients. ENVIRONMENT: The University of Washington represents an ideal environment for Dr Crane's training and for the research she proposes. World-renowned clinical and epidemiological expertise related to HIV and to metabolism are available to support the development of Dr. Crane's research career. RESEARCH: A dramatic decline in overall HIV-related morbidity and mortality has been accompanied by an increase in metabolic complications such as lipodystrophy. The syndrome of lipodystrophy consists of several body morphology abnormalities and is often associated with metabolic abnormalities such as dyslipidemia and glucose intolerance. Why some patients develop these complications and others do not is not understood. Dr. Crane proposes to study body morphology and metabolic abnormalities in a clinical cohort of approximately 1500 patients infected with HIV. This investigation will be facilitated by the University of Washington HIV Information System, a state-of-the art clinical and research database, and by the longitudinal collection of patient-completed measures of body morphology abnormalities, depression, and health-related quality-of-life. This study will examine the association between antiretroviral therapy, patient-related characteristics, and the development of body morphology and metabolic abnormalities. This study will also examine the association between body morphology abnormalities and health-related quality-of-life. Identification of factors that increase or decrease the likelihood of developing metabolic abnormalities may lead to changes in the clinical care of patients with HIV; to advances in understanding the mechanisms that lead to the development of these abnormalities; and ultimately to therapy for these complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23AI060464-04
Application #
7225583
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Brobst, Susan W
Project Start
2004-08-01
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
4
Fiscal Year
2007
Total Cost
$126,306
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Crane, Heidi M; Crane, Paul K; Tufano, James T et al. (2017) HIV Provider Documentation and Actions Following Patient Reports of At-risk Behaviors and Conditions When Identified by a Web-Based Point-of-Care Assessment. AIDS Behav 21:3111-3121
Singh, Sudershan; Willig, James H; Mugavero, Michael J et al. (2011) Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients. Clin Infect Dis 52:387-95
Yoon, Jeanie C; Crane, Paul K; Ciechanowski, Paul S et al. (2011) Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients. AIDS Care 23:1208-18
Crane, Heidi M; Grunfeld, Carl; Willig, James H et al. (2011) Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care. AIDS 25:185-95
Crane, P K; Gibbons, L E; Willig, J H et al. (2010) Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9). AIDS Care 22:874-85
Crane, Heidi M; Grunfeld, C; Harrington, R D et al. (2009) Lipoatrophy and lipohypertrophy are independently associated with hypertension. HIV Med 10:496-503
Kitahata, Mari M; Gange, Stephen J; Abraham, Alison G et al. (2009) Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360:1815-26
Tegger, Mary K; Crane, Heidi M; Tapia, Kenneth A et al. (2008) The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS 22:233-43
Crane, H M; Grunfeld, C; Harrington, R D et al. (2008) Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Med 9:780-6
Crane, Heidi M; Van Rompaey, Stephen E; Kitahata, Mari M (2007) Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine. AIDS Patient Care STDS 21:920-9

Showing the most recent 10 out of 14 publications